Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs Retension Pharmaceuticals, Inc. (RTSN)

Milestone Pharmaceuticals Inc. and Retension Pharmaceuticals, Inc. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and Retension Pharmaceuticals, Inc. are of similar size ($96.6M and $96.2M).

Valuation

Metric MIST RTSN Biotechnology median
P/E n/m — 10.26
P/S 18.07 — 9.18
P/B 5.25 — 2.05
Price to free cash flow n/m — 24.81
EV/EBITDA 0.20 — 0.65
EV/Sales (2.96) — 8.98
Earnings yield (100.00%) — (34.89%)
Free cash flow yield (64.42%) — (24.52%)

Profitability

Metric MIST RTSN Biotechnology median
Gross margin 13.27% — 65.16%
Operating margin (1,479.69%) — 0.00%
Net margin (1,586.01%) — 0.00%
Free cash flow margin (1,163.79%) — 0.00%
Return on equity (35,522.62%) — (50.12%)
Return on assets (73.36%) — (45.60%)
Return on invested capital 0.00% — 0.00%

Growth

Metric MIST RTSN Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (11.94%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MIST RTSN Biotechnology median
Debt to equity 3.25 — 0.00
Current ratio 8.13 — 4.89
Net debt to EBITDA 0.79 — 1.01

Dividend

Metric MIST RTSN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MIST RTSN Biotechnology median
Market cap 96.17m 96.61m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack